NAP1L1 and hepatocellular carcinoma: In addition, the PI3K/AKT/mTOR signaling pathway was inhibited in PRDM8 overexpression by the regulation of NAP1L1 in HCC, which made an antitumor effect (Chen Z. et al., 2018).